ESC Premium Access

Residual risk is still a challenge in HFrEF patients in the modern era

Congress Session

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
70 presentations
1 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Limitations of current therapies in real world - Clinical cases

Speaker: Professor J. Ezekowitz (Edmonton, CA)

Thumbnail

sGC-cGMP: currently an untapped pathway in HFrEF

Speaker: Professor J. Butler (Jackson, US)

Thumbnail

Questions and answers - Closing

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Access the full session

New approach for worsening chronic heart failure

Speakers: Professor F. Zannad, Professor F. Zannad, Professor J. Ezekowitz, Professor J. Butler, Professor F. Zannad
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk